A lupus signal on chromosome 11p15 narrows to a coding haplotype in IRF7 that most people in the world carry. This study shows the risk form moves into the nucleus more readily, binds DNA more tightly and shifts its sequence preference, raising interferon-alpha output, and that mice engineered with the equivalent change clear a respiratory virus better while producing more anti-DNA autoantibodies. The same change buys antiviral protection and costs autoreactivity.
0:00Welcome to Base by Base, the paper cast that brings genomics to you, wherever you are. Thanks for listening and don't forget to follow and rate us in your podcast app. Base-by-base is now on YouTube too, at Base-by-base, where every episode gets a video with chapters and the full description come subscribe.
0:16So, uh, you know, usually when we think about evolution... Write the whole survival of the fittest thing. Yeah, exactly. We picture natural selection acting like this, um, like ruthless bouncer at a club.
0:28Like, it stands at the door of our genetic code, checking IDs, and it just immediately kicks out any genetic mutations that cause, you know, severe or debilitating diseases. It's supposed to protect the population.
0:38Right. It supposed to protect us. But today, we're looking at this massive evolutionary paradox. Oh, it really is. It doesn't make intuitive sense at all. No, it doesn't, because how is it mathematically possible that a genetic variant one that actually puts you at a significantly higher risk for a severe life-altering autoimmune disease?
0:56How is that not just sneaking past the bouncer, but is actually found in, like, up to 98% of some human populations? Yeah, a supposedly bad gene being incredibly successful. Exactly. How could it be so successful?
1:11Well, here's where it gets really interesting. Today's deep dive explores our own DNA to unpack an ancient biological trade-off. We are looking at a hyperactive immune system that attacks the human body, but which, uh, might just be the exact reason our ancestors survive some of the deadliest viral plagues in history.
1:30It's a fascinating tradeoff. But before we dive into the microscopic battlegrounds of the human immune system. Today, we celebrate the work of Samuel J. Vera Lanan, Matthew T. Wirok, Leah C. Katin, and a massive collaborative research team spanning institutions like Cincinnati Children's Hospital Medical Center, and the University of Cincinnati, who have advanced our understanding of the genetic trade-offs between antiviral defense and autoimmunity.
1:54Yeah, and this team, I mean, they really cracked open a mystery surrounding systemic lupus arithhematosis, which, you know, most of us just know is lupus. And for anyone who has like only heard it used as a medical buzzword.
2:07We should probably ground this in what the disease actually looks like for a patient, right? Definitely. a really severe condition. Yeah, it's a debilitating autoimmune condition. It's driven by this widespread chronic inflammation.
2:17The body forms these immune complexes, and it produces what are called auto antibodies. Which basically means the body is turning on itself. Exactly. The immune system is literally manufacturing customized weapons to attack its own healthy tissue, whether that's, you know, the kidneys, the skin, the joints, or even the brain.
2:37And it has a shockingly high heritability rate too. Oh, yeah. somewhere between 43% and 66% across different populations, which is huge. It is. And genetics play a foundational role here. I mean, the medical community has spent years running these massive genome wide association studies, right?
2:55Basically just scanning the DNA of thousands of patients to hunt down the specific genetic risk areas for lupus. Hunting for the culprit. Exactly. And what keeps popping up in these scans is that lupus risk is heavily concentrated in the pathways that control type I interference.
3:08So to understand this, we need to look at the absolute star of the show today, which is a protein called IRF7. Okay, IRF7. Yeah, IRF7. It basically operates as the master regulator of this interfuron response.
3:21So in a healthy scenario, IRF7 acts as a molecular tripwire. A trick wire. Right. When receptors inside a cell detect the presence of a virus. Maybe they sense like viral RNA floating around where it shouldn't be.
3:34They activate IRF7. This protein then travels straight to the command center of the cell, the nucleus, and it binds directly to the DNA. Wow. Okay. Yeah, and that triggers a massive inflammatory cascade.
3:46It forces the cell to secrete interferons, which are basically chemical warning signals that tell neighboring cells to shut down and stop the virus from replicating. I always, I always picture IRF7 as a home security system.
3:58Oh that's a good way to look at it. Yeah, like under normal circumstances. It's doing exactly what you wanted to do, right? It senses a burglar, breaking a window, the virus, and it immediately triggers the alarm, locks all the doors and calls the police.
4:10Exactly. It protects the house. Yeah. But in someone with lupus, this alarm system seems to be calibrated so incredibly high and it's so hypersensitive that it goes off when, like, a leaf just blows across the lawn.
4:23Right, a total overreaction. Yeah. The body's own natural debris, like the dead cells we naturally shed every day, bump into the sensor, and the system panics, and suddenly you have a massive SWAT team, tearing up the house for no reason, causing immense collateral damage.
4:38And the problem with an alarm calibrated that high is exactly what the research team wanted to investigate. They zeroed in on a specific genetic variant on chromosome 11. Okay. I identified what called a coding haplotype, which is essentially a cluster of DNA variations that tend to be inherited together.
4:56And these specific variations actually change the physical amino acid building blocks of the IRF7 protein. They literally change the structure. They do, but honestly, the most staggering part of their discovery isn't just the mutation itself.
5:09It's the global prevalence. I mean, most autoimmune risk variants are extremely rare, right? Natural selection usually weeds them out because they harm the host. Right. The bouncer kicks him out. Exactly.
5:20But this lupus risk variant is globally dominant. The data shows it is found in about 42% of people with African ancestry. Wow. Around 73% and those of European ancestry, and an astonishing 98% in people of East Asian ancestry.
5:35Wait, 98%? Yep. Almost everyone in that group. I mean, if nearly everyone in a specific population has it, we can't even call it a rare disease mutation anymore. It is practically standard human operating equipment in that demographic.
5:50It really is. It's the norm. But if this mutation is so widespread and supposedly ancient, how on earth do researchers today prove what it was doing in our ancestor cells, like tens of thousands of years ago versus what it's doing in a modern lupus patient, you can't exactly draw blood from a Neanderthal?
6:09No, you definitely can't. It requires blending ancient archaeology with modern molecular biology. So to look back in time, the team turned to the ancient genome diversity project. Okay, what is that? It's this massive database containing genomes, sequence from human remains dating back up to 43,000 years.
6:2743,000? That's incredible. It is, but ancient DNA is highly degraded. It's fragmented, meaning the researchers couldn't always find the exact genetic letters of this specific IRS 7 variant in the fossil record.
6:41Oh, because the DNA literally fell apart over time. Right. So to get around this, they used a proxy marker. They found a different nearby genetic variation, specifically RS 11246213, that is perfectly linked to our lupus risk variant in modern humans.
6:58Ah, so they always travel together. Exactly. By tracking this durable proxy marker through the ancient DNA database, they could essentially trace the evolutionary footprint of this hyperactive immune variant across millennia.
7:10So they track its footprint through history to prove it was there. But to figure out the actual mechanics, like how it physically behaves inside a cell, they had to bring it into the modern lab, right?
7:18They did. The paper mentions they used CRISPR technology to engineer specific human cell lines. They took, um, Common laboratory lines of human lung tissue, like HGK cells, THP1 monocytes and A549 lung epithelial cells, which are obviously critical for immunity.
7:37Right, very standard reliable models. And they essentially went in with molecular scissors, stripped out the natural IRF7 gene, and dropped in either the lupus risk version or the loopus protective version.
7:49And by creating these custom cell lines, the isolated the variable. They can watch exactly how the 2 different versions of the protein interact with human DNA. How do you even measure that though? Well, they utilize a technology called protein binding micro arrays or PDMs.
8:03You could think of it as a massive microscopic testing grid containing over 10,000 different synthetic DNA sequences. 10,000. Wow. Yeah. They expose these arrays to the engineered IRF7 proteins. This allowed them to measure with incredible precision, not just where the proteins bind, but how tightly the risk variant grips the DNA compared to the protective variant, and whether the mutation changes its preference for specific genetic codes.
8:30Okay, I can visualize that. It's like testing different types of Velcro to see which one holds on the tightest. That's great analogy. But the methodology didn't stop at Petri dishes. They also brought this into mouse models.
8:40They used CRISPR to edit the mouse version of this gene, swapping out just one single amino acid to mimic the human lupus risk variant. The ARG 334 GL edit, yeah. Okay, let's unpack this for a second. I always push back a little when I see mouse models used for complex human immune diseases.
8:57Like a mouse is not just a tiny human, right? Their immune systems evolved in completely different environments. That is a very valid point. So can we really equate a mouse's biological alarm system to ours?
9:09It is a fundamental question in immunology. And honestly, the researchers address it head on. If you look at the entirety of the human IRF 7 protein and the mouse equivalent, they only share about a 69% overall identity.
9:23See, that doesn't sound very high. It doesn't. However, the research is specifically focused on the domains that matter for this experiment. The DNA binding domain, which grabs the genetic code and the inhibitory domain, which acts as the brakes.
9:38Ah, okay. In those specific highly specialized regions, humans and mice share greater than 95% amino acid identity. Oh, wow. Okay, that's huge. Right. Furthermore, all standard laboratory mouse strains naturally carry the protective non-lupus version of this gene.
9:55By using CRISPR to swap just that one targeted amino acid to match the human risk variant. They created an incredibly precise, highly relevant model. So they could observe the systemic effects without other noise.
10:07Exactly. To observe the full body effects of this specific genetic change without the noise of other human genetic variables. Okay, yeah. When you frame it around the 95% similarity and the specific braking mechanism of the protein, the mouse model makes a lot of sense.
10:22So we have this massive multi-tiered investigation. We have ancient DNA tracing the evolutionary history. We have engineered human lung and immune cells testing the grip strength on the DNA, and we have CRISPR edited mice to observe the whole body effects.
10:37When they put all this data together, What did they actually find? Well, the ancient DNA analysis painted a fascinating picture of human survival. This lupus risk variant was not a recent genetic fluke or some isolated mutation.
10:50It had been around a while. A long while. The proxy markers showed it was already highly prevalent in global populations by 10,000 BCE. 10,000 BCE. Yep. And more importantly, it persisted steadily through history right up to the modern era.
11:05When a gene that causes a severe disease maintains that kind of high frequency across multiple ancestries for tens of thousands of years, I mean, it violates the normal rules of natural selection. Right.
11:17The bouncer let it stay in the club for millennia. Exactly. It strongly suggests that carrying this mutation provided a massive immediate survival benefit. It was being actively selected for by environmental pressures, despite the long term autoimmune risk it carried.
11:31And the modern cellular work finally revealed the physical mechanics, so that survival benefit, right? Yes, it did. Because when the researchers took those engineered human cells and applied a viral mimic, like polyic or are 848, which are basically chemicals that trick the cell into thinking it has just been infected by a dangerous virus, the 2 different gene variants behaved radically different.
11:55Completely differently. The lupus risk IRF7 variant flooded into the cell's nucleus, the command center, significantly faster than the protective variant. Because the mutation alters the inhibitory domain of the protein, which effectively removes the biological brakes.
12:09And because it rushes into the nucleus so aggressively, the dynamics of how it interacts with our DNA completely changed. So what did the Velcro test show? The protein binding micro array tests showed a dramatic difference in grip strength.
12:22The risk variant buying much more tightly to the DNA. It tends to act as a homotymer. A homodymer, meaning what, exactly? Which means 2 IRF7 proteins lashed together, forming a paired complex that grabs onto the DNA sequence with incredible force.
12:37The protective variant, in contrast, exhibited much weaker binding and didn't hold on with the same intensity. Okay, so if 2 proteins are locking together and clamping down on the DNA that tightly, the output of the cell has to change, and it does.
12:51Because it floods the nucleus and binds like a vice grip, the cells carrying the lupus risk variant pumped out roughly twofold more interfere on alpha, MRNA, and protein compared to the protective variant.
13:02Double the output. Yeah, the biological amplifier is cranked up, it doubling the body's antiviral response. But what does a twofold increase actually mean on the biological battlefield? Like how does simply doubling the interfere on clear a virus or cause a disease?
13:15Well, to understand the battlefield. We have to look at what Interferon actually does. When a cell secretes interferon. It binds to receptors on the outside of neighboring cells. This triggers a panic response in those neighbors.
13:28Like sounding the alarm. Exactly. It causes them to shut down their internal protein factories and destroy any loose RNA. It essentially starves the virus, preventing it from hijacking the cell to make copies of itself.
13:41That sounds intense. It is. A twofold increase means this scorched earth tactic is deployed faster, wider, and with far more intensity. The infection is walled off and eradicated rapidly. But the cost of this intense shutdown is severe cellular stress and tissue damage.
13:57Ah I see. If this happens constantly, the collateral damage accumulates, leading to the inflammation and ergon damage characteristic of an autoimmune disease. And that perfectly sets up why the mouse models were the ultimate proof of this trade-off.
14:10They took those CRISPR edited mice with the risk variant and subjected them to an autoimmune trigger over several weeks. And the mice carrying the risk variant develops significantly higher levels of anti-DS DNA auto antibodies.
14:24They displayed clear, exacerbated, lupus like autoimmune symptoms compared to the control mice, that the collateral damage you were just talking about. The alarm system is tearing the house down. It really is.
14:35But then, to prove the other half of the paradox, they ran a survival test. Yes, they infected both groups of mice with a live, dangerous pathogen. The vesicular stomatitis virus where VSV, and the results were striking.
14:49The exact same mice with the risk variant, the ones that had just developed severe autoimmune symptoms had significantly lower viral tiders in their lungs. Wow. They fought off the live virus much more effectively than the control mice.
15:02Because their immune system was blasting that double dose of interferon, they cleared the infection faster. What's fascinating here is that this is explicit proof of an evolutionary tradeoff. It really is the ultimate evolutionary bargain.
15:14The gene dial is turned all the way up to 11 to clear deadly respiratory infections quickly, ensuring that the human host survives the immediate existential threat of a plague. Survive today, pay for it tomorrow.
15:24Exactly. But that same high volume response damages the host's own tissue over time, driving a chronic autoimmune disease once the acute viral threat is gone. Surviving a pandemic at age 20 means you might develop lupus at age 40.
15:39And this trade-off mechanism directly addresses the clinical reality we see in modern medicine. This double output amplifier explains the IFNA signature that is clinically observed in over 50% of human lupus patients today.
15:52Okay, so tying it back to the patients. Right. In a healthy scenario, the pathway is triggered by a real virus does its aggressive job and then gracefully shuts down. But in a lupus patient, the endogenous material we mentioned earlier, the body's own dead cells or misplaced DNA constantly bumps into the sensors.
16:10Just normal bodily debris. Yeah. And because these patients carry this highly prevalent risk variant, Every single time the pathway is accidentally triggered. It produces double the inflammatory interference.
16:21Over months and years, this recurrent, higher amplitude response, cumulatively sustains chronic tissue damaging disease. The researchers have basically pinpointed IRF7 is the vital nodal point, the exact intersection where host defense and autoimmunity collide.
16:38Which naturally leads to the big question for anyone suffering from this disease today. I mean, we aren't actively fighting off the historical bubonic or antonine plagues that's selected for this gene.
16:48So, what does this all mean for treatments? Could we theoretically just dial down IRF7 in lupus patients to stop the auto antibodies without destroying their ability to fight off a winter flu? I mean, it is the logical next step for drug design, but it highlights a massive clinical limitation discussed in the study.
17:04Modulating IRF 7 therapeutically requires extreme precision because you're tinkering with the master switch of antiviral defense. It's a delicate balance. Very delicate. The paper specifically notes that humans who are born completely deficient in IRF7, where the gene doesn't work at all, are incredibly susceptible to severe life-threatening respiratory viruses, including influenza and SARSCOVID 2.
17:28Oh, wow. Yeah, you cannot just turn the system off to cure the lupus. Doing so would leave the patient dangerously vulnerable to everyday pathogens. Right. You can't just unplug the security system entirely because you're annoyed at the false alarms.
17:39You need to find a way to recalibrate the sensor so it stops freaking out over blowing leaves, but, you know, still catches the actual burglars. Precisely. And looking forward, the researcher suggests that the path to that recalibration lies in specific immune cells.
17:54Future studies need to focus on plasma cytoid dendritic cells or PDCs. PDCs, okay. Yeah, these are rare, specialized immune cells that act as the body's major, professional interferon factories. And their function is heavily dependent on IRF7, mapping out exactly how this specific risk capital type behaves inside PDCs is the next logical step to fully unraveling the pathway for targeted therapies.
18:17makes sense. It is also worth noting that while the ancient DNA data is robust regarding the age of the variant, a mystery remains. Ooh, a mystery. The exact historical plagues or evolutionary bottlenecks that drove the dramatic ancestry specific frequency differences, like why it reached 98% in East Asian ancestry, but remained of 42% in African ancestry remain unconfirmed.
18:41The sampling of ancient DNA is still geographically uneven, so we cannot yet point to one specific historical viral event that forced this genetic adaptation. Man, it's incredible to think that the unseen viral wars fought by our ancestors thousands of years ago are still actively dictating how our immune systems behave right now, like we are literally carrying the genetic scars of ancient pandemics.
19:03We really are. To summarize the core findings of this investigation. The highly prevalent lupus risk IRF7 haplotype acts as a biological amplifier, doubling the production of type I interferons. While this hyperactive immune response gave our ancestors a critical evolutionary advantage against deadly viruses, it persists today as a potent driver of autoimmune diseases like systemic lupus arithmetosis.
19:25What does this mean for the future of personalized medicine when our own genes represent an ancient compromise between surviving the plague and living with chronic disease? This episode was based on an open access article under the CCBY 4 license.
19:40You can find a direct link to the paper and the license in our episode description. If you enjoyed this, follow or subscribe in your podcast app and leave a 5 star rating. If you'd like to support our work, use the donation link in the description.
19:53Now, stay with us for an original track created especially for this episode and inspired by the article you've just heard about. Thanks for listening and join us next time as we explore more science base by base.
